Ovoca Gold PLC (OVXA) - Total Liabilities
Based on the latest financial reports, Ovoca Gold PLC (OVXA) has total liabilities worth €967.00K EUR (≈ $1.13 Million USD) as of December 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Ovoca Gold PLC operating cash flow efficiency to assess how effectively this company generates cash.
Ovoca Gold PLC - Total Liabilities Trend (1987–2023)
This chart illustrates how Ovoca Gold PLC's total liabilities have evolved over time, based on quarterly financial data. See shareholders equity of Ovoca Gold PLC for net asset value and shareholders' equity analysis.
Ovoca Gold PLC Competitors by Total Liabilities
The table below lists competitors of Ovoca Gold PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CENTAURUS ENERGY INC.
F:72M0
|
Germany | €5.59 Million |
|
Migo Opportunities Trust PLC
LSE:MIGO
|
UK | GBX11.69 Million |
|
Upgrade Invest Nordic AB
ST:UPGRAD
|
Sweden | Skr46.00K |
|
Accelerate Diagnostics Inc
NASDAQ:AXDX
|
USA | $84.60 Million |
|
IG Design Group plc
LSE:IGR
|
UK | GBX110.62 Million |
|
AOTI Inc
LSE:AOTI
|
UK | GBX36.64 Million |
|
Magnum Goldcorp Inc
V:MGI
|
Canada | CA$144.78K |
|
Venture Life Group PLC
LSE:VLG
|
UK | GBX17.76 Million |
Liability Composition Analysis (1987–2023)
This chart breaks down Ovoca Gold PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Ovoca Gold PLC.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ovoca Gold PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ovoca Gold PLC (1987–2023)
The table below shows the annual total liabilities of Ovoca Gold PLC from 1987 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €967.00K ≈ $1.13 Million |
-45.37% |
| 2022-12-31 | €1.77 Million ≈ $2.07 Million |
+31.99% |
| 2021-12-31 | €1.34 Million ≈ $1.57 Million |
+175.93% |
| 2020-12-31 | €486.00K ≈ $568.19K |
+13.82% |
| 2019-12-31 | €427.00K ≈ $499.21K |
-63.66% |
| 2018-12-31 | €1.18 Million ≈ $1.37 Million |
+2454.35% |
| 2017-12-31 | €46.00K ≈ $53.78K |
-78.80% |
| 2016-12-31 | €217.00K ≈ $253.70K |
-19.33% |
| 2015-12-31 | €269.00K ≈ $314.49K |
-9.73% |
| 2014-12-31 | €298.00K ≈ $348.39K |
-87.87% |
| 2013-12-31 | €2.46 Million ≈ $2.87 Million |
-79.08% |
| 2012-12-31 | €11.74 Million ≈ $13.73 Million |
-10.55% |
| 2011-12-31 | €13.13 Million ≈ $15.35 Million |
-0.80% |
| 2010-12-31 | €13.23 Million ≈ $15.47 Million |
+619.68% |
| 2009-12-31 | €1.84 Million ≈ $2.15 Million |
+34.63% |
| 2008-12-31 | €1.37 Million ≈ $1.60 Million |
+14.50% |
| 2007-12-31 | €1.19 Million ≈ $1.39 Million |
+29.39% |
| 2006-12-31 | €922.00K ≈ $1.08 Million |
+65.83% |
| 2005-12-31 | €556.00K ≈ $650.02K |
+159.81% |
| 2004-12-31 | €214.00K ≈ $250.19K |
+27.38% |
| 2003-12-31 | €168.00K ≈ $196.41K |
-28.81% |
| 2002-12-31 | €236.00K ≈ $275.91K |
+28.26% |
| 2001-12-31 | €184.00K ≈ $215.12K |
-11.11% |
| 2000-12-31 | €207.00K ≈ $242.00K |
+5.61% |
| 1999-12-31 | €196.00K ≈ $229.14K |
-23.44% |
| 1998-12-31 | €256.00K ≈ $299.29K |
-23.81% |
| 1997-12-31 | €336.00K ≈ $392.82K |
+88.76% |
| 1996-12-31 | €178.00K ≈ $208.10K |
-37.98% |
| 1995-12-31 | €287.00K ≈ $335.53K |
-8.31% |
| 1994-12-31 | €313.00K ≈ $365.93K |
+16.36% |
| 1993-12-31 | €269.00K ≈ $314.49K |
+45.41% |
| 1992-12-31 | €185.00K ≈ $216.28K |
+56.78% |
| 1991-12-31 | €118.00K ≈ $137.95K |
-27.61% |
| 1990-12-31 | €163.00K ≈ $190.56K |
-10.93% |
| 1989-12-31 | €183.00K ≈ $213.95K |
+531.03% |
| 1988-12-31 | €29.00K ≈ $33.90K |
+123.08% |
| 1987-12-31 | €13.00K ≈ $15.20K |
-- |
About Ovoca Gold PLC
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It's lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporate… Read more